GSK, Roche Spar Over Herceptin Patents
GlaxoSmithKline LLC is facing off against Roche Holding Ltd. and its subsidiary Genentech Inc. in dueling patent infringement suits over breast cancer treatment drug Herceptin....To view the full article, register now.
Already a subscriber? Click here to view full article